Primary Care/Hospitalist
RSSArticles
-
Patient Pool Eligible for Lung Cancer Screening Expands Under Amended Criteria
CMS lowers age, smoking history thresholds.
-
Clindamycin Vaginal Gel 2% (Xaciato)
Clindamycin gel can be prescribed to treat bacterial vaginosis in women age 12 years and older.
-
Screen Older Heart Failure Patients for Transthyretin Cardiac Amyloidosis
A screening study of heart failure patients ≥ age 60 years, left ventricular ejection fraction ≥ 40%, and left ventricle wall thickness ≥ 12 mm revealed 6.3% prevalence of transthyretin cardiac amyloidosis, a highly treatable disease.
-
Is Physical Activity Associated with Mortality Risk in Parkinson’s Disease?
In individuals with Parkinson’s disease (PD), physical activity (PA) at all intensities was associated with lower all-cause mortality rates, with the greatest reduction seen in individuals who maintained PA before and after PD diagnosis.
-
Multiple Sclerosis and Immune Response to COVID-19 Vaccination
A large group of patients with multiple sclerosis taking various disease-modifying therapies did not respond uniformly to COVID-19 vaccination.
-
Social Isolation, Older Adults, and Mortality Post-ICU
Social isolation among older adults admitted to the ICU was associated with worse disability burden and higher one-year mortality rates after critical illness.
-
Consume Olive Oil, Live Longer
Consuming more olive oil was associated with lower cardiovascular and all-cause mortality. Substituting margarine, butter, mayonnaise, and dairy fat with olive oil also was associated with lower mortality risk.
-
U.S. Chlamydia Rates Continue to Climb
The chlamydia infection rate has been rising unabated. While rates of some STIs have fluctuated over the past 40 to 80 years, chlamydia rates have increased progressively since the first reporting data became available in 1984. -
Herpes Vaccine Could Be Available by 2030
Early efforts to produce a protein-based vaccine for herpes failed. But a new mRNA approach has outperformed the efficacy of the past vaccines in preclinical trials and is expected to be introduced in clinical trials in the second half of 2022, investigators say. This new approach for a prophylactic genital herpes vaccine showed great promise in early studies.
-
STI Rates Increasing, but Efficient Testing Can Help
Incidence rates of many sexually transmitted infections (STIs) have increased in the years leading up to the COVID-19 pandemic. There is evidence that STIs have continued to rise during the pandemic, according to the results of a new study.